• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺切除标本中不同肿瘤生长模式下前列腺特异性抗原表达的变化。

Variation of prostate-specific antigen expression in different tumour growth patterns present in prostatectomy specimens.

作者信息

Gallee M P, Visser-de Jong E, van der Korput J A, van der Kwast T H, ten Kate F J, Schroeder F H, Trapman J

机构信息

Department of Pathology, Erasmus University, Rotterdam, The Netherlands.

出版信息

Urol Res. 1990;18(3):181-7. doi: 10.1007/BF00295844.

DOI:10.1007/BF00295844
PMID:1697709
Abstract

A series of 55 randomly chosen radical prostatectomy specimens was analyzed for expression of prostate-specific antigen (PSA) by immunohistochemical techniques. Tissue sections were selected in such a manner that in addition to glandular benign prostatic hyperplasia (BPH), one or more different prostatic tumour growth patterns were present. Four monoclonal antibodies, directed against three different PSA epitopes, and one polyclonal anti-PSA antiserum were used. Expression of PSA was compared with that of prostate-specific acid phosphatase (PAP), recognized by two different polyclonal antisera. A critical dilution aimed at a maximum of staining intensity on BPH tissue sections was chosen for all antibodies. Anti-PSA and anti-PAP antisera stained essentially all BPH samples (over 90%). Irrespective of the nature of the antibodies used, PSA expression was found to be decreased in prostatic carcinoma. A clear cut relationship was found between immunoreactivity for PSA and the degree of differentiation of the tumour area. Under the experimental conditions used the PSA monoclonal antibodies stained only 1 out of 10 undifferentiated carcinomas, whereas 50% to 70% of the well- and moderately-differentiated carcinomas showed immunoreactivity. This correlation was less pronounced with the PAP staining pattern. If the PSA antibody titer was raised the percentage of clearly staining undifferentiated carcinomas could be considerably increased (up to 60%-100%), indicating that PSA expression is not absent, but lowered in most (if not all) undifferentiated carcinomas.

摘要

通过免疫组织化学技术对55例随机选取的根治性前列腺切除术标本进行分析,以检测前列腺特异性抗原(PSA)的表达。组织切片的选取方式使得除了腺性良性前列腺增生(BPH)外,还存在一种或多种不同的前列腺肿瘤生长模式。使用了针对三种不同PSA表位的四种单克隆抗体以及一种多克隆抗PSA抗血清。将PSA的表达与两种不同多克隆抗血清识别的前列腺特异性酸性磷酸酶(PAP)的表达进行比较。为所有抗体选择了一个临界稀释度,旨在使BPH组织切片上的染色强度达到最大。抗PSA和抗PAP抗血清对基本上所有BPH样本(超过90%)都有染色。无论所用抗体的性质如何,在前列腺癌中都发现PSA表达降低。在PSA的免疫反应性与肿瘤区域的分化程度之间发现了明确的关系。在所使用的实验条件下,PSA单克隆抗体在10例未分化癌中仅对1例有染色,而50%至70%的高分化和中分化癌显示有免疫反应性。这种相关性在PAP染色模式中不太明显。如果提高PSA抗体滴度,明显染色的未分化癌的百分比会大幅增加(高达60%-100%),这表明在大多数(如果不是全部)未分化癌中PSA表达并非不存在,而是降低了。

相似文献

1
Variation of prostate-specific antigen expression in different tumour growth patterns present in prostatectomy specimens.前列腺切除标本中不同肿瘤生长模式下前列腺特异性抗原表达的变化。
Urol Res. 1990;18(3):181-7. doi: 10.1007/BF00295844.
2
Evaluation of PAP and PSA gene expression in prostatic hyperplasia and prostatic carcinoma using northern-blot analyses, in situ hybridization and immunohistochemical stainings with monoclonal and bispecific antibodies.使用Northern印迹分析、原位杂交以及单克隆和双特异性抗体的免疫组织化学染色法评估前列腺增生和前列腺癌中PAP和PSA基因的表达。
Int J Cancer. 1993 Oct 21;55(4):590-7. doi: 10.1002/ijc.2910550413.
3
Immunohistochemical distribution of the three predominant secretory proteins in the parenchyma of hyperplastic and neoplastic prostate glands.
Prostate. 1988;12(1):39-46. doi: 10.1002/pros.2990120106.
4
Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker.人腺体激肽释放酶2(hK2)在前列腺上皮内瘤变和腺癌中的表达:一种新型前列腺癌标志物。
Urology. 1997 Jun;49(6):857-62. doi: 10.1016/s0090-4295(97)00108-8.
5
Changes in immunohistochemical staining of PSA, PAP, and TURP-27 following irradiation therapy for clinically localized prostate cancer.临床局限性前列腺癌放射治疗后前列腺特异性抗原(PSA)、前列腺酸性磷酸酶(PAP)和TURP - 27免疫组化染色的变化
Urology. 1994 Oct;44(4):525-9. doi: 10.1016/s0090-4295(94)80051-0.
6
Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.前列腺特异性抗原作为前列腺腺癌的血清标志物。
N Engl J Med. 1987 Oct 8;317(15):909-16. doi: 10.1056/NEJM198710083171501.
7
Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate.前列腺特异性抗原:对前列腺腺癌最有用的肿瘤标志物的批判性评估。
J Urol. 1991 May;145(5):907-23. doi: 10.1016/s0022-5347(17)38491-4.
8
Evaluation of a monoclonal immunoradiometric assay for prostate-specific antigen.前列腺特异性抗原单克隆免疫放射分析方法的评估
Clin Chem. 1987 Dec;33(12):2257-61.
9
Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen.对人前列腺癌进行癌胚抗原、非特异性交叉反应抗原、β-绒毛膜促性腺激素和前列腺特异性抗原的免疫细胞化学评估。
Cancer Res. 1984 Jan;44(1):285-92.
10
The relation of prostatic acid phosphatase and prostate specific antigen with tumour grade in prostatic adenocarcinoma: an immunohistochemical study.前列腺酸性磷酸酶和前列腺特异性抗原与前列腺腺癌肿瘤分级的关系:一项免疫组织化学研究。
Prog Clin Biol Res. 1990;357:129-34.

引用本文的文献

1
The HeyL-Aromatase Axis Promotes Cancer Stem Cell Properties by Endogenous Estrogen-Induced Autophagy in Castration-Resistant Prostate Cancer.HeyL-芳香化酶轴通过内源性雌激素诱导的自噬促进去势抵抗性前列腺癌中的癌症干细胞特性。
Front Oncol. 2022 Jan 12;11:787953. doi: 10.3389/fonc.2021.787953. eCollection 2021.
2
Understanding and targeting prostate cancer cell heterogeneity and plasticity.理解和靶向前列腺癌细胞异质性和可塑性。
Semin Cancer Biol. 2022 Jul;82:68-93. doi: 10.1016/j.semcancer.2021.11.001. Epub 2021 Nov 26.
3
Profiling of Androgen-Dependent Enhancer RNAs Expression in Human Prostate Tumors: Search for Malignancy Transition Markers.

本文引用的文献

1
Prostate antigen: a marker for human prostate epithelial cells.前列腺抗原:一种人类前列腺上皮细胞的标志物。
J Natl Cancer Inst. 1981 Jan;66(1):37-42.
2
Immunochemical evaluation of the organ specificity of prostatic acid phosphatase.前列腺酸性磷酸酶器官特异性的免疫化学评估。
Clin Chem. 1981 Sep;27(9):1505-12.
3
Immunoperoxidase staining of acid phosphatase in human prostatic tissue.
J Urol. 1982 Nov;128(5):1114-6. doi: 10.1016/s0022-5347(17)53356-x.
人前列腺肿瘤中雄激素依赖性增强子RNA表达谱分析:寻找恶性转化标志物。
Res Rep Urol. 2021 Sep 14;13:705-713. doi: 10.2147/RRU.S328661. eCollection 2021.
4
Phage display screening identifies a prostate specific antigen (PSA) prostate cancer cell specific peptide to retard castration resistance of prostate cancer.噬菌体展示筛选鉴定出一种前列腺特异性抗原(PSA)前列腺癌细胞特异性肽,以延缓前列腺癌的去势抵抗。
Transl Oncol. 2021 Mar;14(3):101020. doi: 10.1016/j.tranon.2021.101020. Epub 2021 Jan 26.
5
Molecular MR Imaging of Prostate Cancer.前列腺癌的分子磁共振成像
Biomedicines. 2020 Dec 22;9(1):1. doi: 10.3390/biomedicines9010001.
6
Gene Expression Alterations during Development of Castration-Resistant Prostate Cancer Are Detected in Circulating Tumor Cells.在去势抵抗性前列腺癌发展过程中的基因表达改变可在循环肿瘤细胞中检测到。
Cancers (Basel). 2019 Dec 21;12(1):39. doi: 10.3390/cancers12010039.
7
Prognostic and diagnostic role of PSA immunohistochemistry: A tissue microarray study on 21,000 normal and cancerous tissues.前列腺特异性抗原免疫组化的预后及诊断作用:一项对21000份正常和癌组织的组织芯片研究
Oncotarget. 2019 Sep 10;10(52):5439-5453. doi: 10.18632/oncotarget.27145.
8
Rectal Invasion by Prostatic Adenocarcinoma That Was Initially Diagnosed in a Rectal Polyp on Colonoscopy.最初在结肠镜检查时于直肠息肉中诊断出的前列腺腺癌侵犯直肠
J Pathol Transl Med. 2019 Jul;53(4):266-269. doi: 10.4132/jptm.2019.03.25. Epub 2019 Apr 11.
9
Update on histopathological evaluation of lymphadenectomy specimens from prostate cancer patients.前列腺癌患者淋巴结切除标本的组织病理学评估最新进展
World J Urol. 2017 Apr;35(4):517-526. doi: 10.1007/s00345-015-1752-8. Epub 2015 Dec 22.
10
Systematic dissection of phenotypic, functional, and tumorigenic heterogeneity of human prostate cancer cells.对人类前列腺癌细胞的表型、功能和致瘤异质性进行系统剖析。
Oncotarget. 2015 Sep 15;6(27):23959-86. doi: 10.18632/oncotarget.4260.
4
The proteolytic activity of human prostate-specific antigen.人前列腺特异性抗原的蛋白水解活性。
Biochem Biophys Res Commun. 1984 Sep 17;123(2):482-8. doi: 10.1016/0006-291x(84)90256-0.
5
Immunohistochemical localization of prostate-specific acid phosphatase and prostate-specific antigen in stage A2 adenocarcinoma of the prostate: prognostic implications.前列腺特异性酸性磷酸酶和前列腺特异性抗原在A2期前列腺腺癌中的免疫组织化学定位:预后意义
Hum Pathol. 1984 Sep;15(9):853-9. doi: 10.1016/s0046-8177(84)80146-x.
6
Evaluation of prostate specific acid phosphatase and prostate specific antigen in identification of prostatic cancer.
J Urol. 1983 Feb;129(2):315-8. doi: 10.1016/s0022-5347(17)52074-1.
7
Prostatic cancer presenting as metastatic adenocarcinoma of undetermined origin. Immunodiagnosis by prostatic acid phosphatase.表现为原发灶不明的转移性腺癌的前列腺癌。前列腺酸性磷酸酶免疫诊断法。
Cancer. 1983 Jan 15;51(2):283-7. doi: 10.1002/1097-0142(19830115)51:2<283::aid-cncr2820510220>3.0.co;2-5.
8
Immunohistochemical acid phosphatase level and tumor grade in prostatic carcinoma.前列腺癌中免疫组织化学酸性磷酸酶水平与肿瘤分级
Arch Pathol Lab Med. 1982 Sep;106(9):476-80.
9
Monoclonal antibody (F5) to human prostate antigen.针对人类前列腺抗原的单克隆抗体(F5)
Hybridoma. 1983;2(2):139-47. doi: 10.1089/hyb.1983.2.139.
10
Multiple immunoperoxidase markers in benign hyperplasia and adenocarcinoma of the prostate.前列腺良性增生和腺癌中的多种免疫过氧化物酶标志物
Am J Clin Pathol. 1984 Mar;81(3):279-84. doi: 10.1093/ajcp/81.3.279.